MOTS-c
Also known as: Mitochondrial ORF of the 12S rRNA type-c
The Exercise Mimetic
MOTS-c activates AMPK like exercise does. It's being studied for metabolic benefits without hitting the gym.
How It Works
Simple Explanation
Activates the same cellular pathways that exercise does, improving metabolism and insulin sensitivity.
Technical Details
Mitochondria-derived peptide that activates AMPK, improves glucose uptake, and enhances fatty acid oxidation.
Pharmacokinetics & Storage
Half-Life
~4-6 hours (estimated from animal studies)
Duration in circulation
Storage Requirements
MOTS-c is relatively fragile. Reconstitute with bacteriostatic water. Avoid repeated freeze-thaw cycles.
Research Timeline: What Studies Have Observed
Based on clinical trial data and published research. Individual responses may vary significantly.
Week 1-2
Research indicates metabolic effects begin quickly. Animal studies show AMPK activation within days. Some report improved energy.
Weeks 3-4
Studies document insulin sensitivity improvements becoming measurable. Exercise tolerance may improve per animal research.
Weeks 6-8
Clinical research suggests metabolic markers show improvement. Studies in mice showed significant body composition changes by this point.
Weeks 12+
Research indicates ongoing metabolic benefits with continued use. Longevity studies in animals suggest long-term protective effects.
Benefits
- Exercise-mimetic effects
- Improved insulin sensitivity
- Enhanced metabolism
- Potential longevity benefits
- May protect against obesity
Potential Side Effects
Injection site reaction
Occasional
Fatigue initially
Rare
Known Interactions
Based on clinical research and pharmacological studies. Always consult a healthcare provider about potential interactions.
Metformin
cautionBoth activate AMPK. Research suggests potential additive effects on glucose metabolism. Monitor blood sugar carefully.
Diabetes medications
cautionMOTS-c affects glucose and insulin. Blood sugar monitoring important if combining with diabetes drugs.
Exercise
monitorMOTS-c mimics some exercise pathways. Research indicates it may enhance exercise adaptations rather than replace exercise.
Research Highlights
MOTS-c Human Trial (2024)
First human trial demonstrated improved insulin sensitivity and glucose metabolism
View StudyMitochondrial Function Review (2023)
Comprehensive review establishes MOTS-c as a promising exercise mimetic compound
View StudyFrequently Asked Questions
Can MOTS-c replace exercise?
How does MOTS-c affect insulin sensitivity?
Is MOTS-c good for longevity?
What's the connection to mitochondria?
Who Is It For
- Metabolic optimization
- Those unable to exercise
- Longevity enthusiasts
- Obesity prevention
Who Should Avoid
- Unknown safety in pregnancy
- Those on diabetes medications (consult doctor)
How It Compares
Research-based comparisons with similar peptides. Individual responses and circumstances should guide decisions.
Semaglutide provides proven weight loss through appetite suppression. MOTS-c works through metabolic pathways. Different mechanisms - semaglutide is FDA-approved with more data.
Both target longevity but through different mechanisms. Epithalon affects telomeres; MOTS-c affects metabolism. Potentially complementary.
Research Dosing Protocols
Common Research Protocol
5-10mg weekly
Administration Frequency (per studies)
1-3x weekly
Delivery Methods
Available Forms
- • Subcutaneous injection
⚠️ Not Medical Advice: Dosing information is compiled from published research and clinical studies for educational purposes only. This is not a recommendation. All peptide research should be conducted by qualified professionals in controlled research environments. Consult a healthcare provider before considering any protocol.
Cost Context
Research-grade MOTS-c: $60-120 per 5mg vial. Monthly cost: $100-300 depending on protocol. More expensive than simpler peptides due to complex synthesis.
Prices vary by region, source, and insurance coverage. This is general context only.
Related Peptides
⚠️ Important Disclaimer
This information is for educational purposes only and is not medical advice. Many peptides discussed are research compounds not approved for human use by the FDA. Always consult with a qualified healthcare provider before starting any peptide protocol. PepGains does not sell peptides and is not responsible for how this information is used. All timeline and efficacy information is based on published research and clinical trials - individual results may vary significantly.